Edwards Lifesciences Corporatio Price Today
Edwards Lifesciences Corporatio
EW
Healthcare
$55.58B
💰
Market Cap
40.1
💸
Price to Earnings
$2.3
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
16 |
Strong Buy |
8 |
Hold |
13 |
Sell |
0 |
Strong Sell |
2 |
EW Price Forecast Target
92.3 👉 105.0 +14%
EW EPS Forecast
2.3 👉 3.1 +34%
Financials
Profit Margin
23 %
Revenue Growth
13.8 %
Dividend
$ 0
Held Percent
0.9% - Insiders
84.0% - Institutions
15.1% - Public
Major Fund Holders
-
💰 $
-
💰 $
-
💰 $
-
💰 $
-
💰 $
Stock Ideas
Michael Burry Portfolio
Michael Burry, the renowned value investor and founder of Scion Asset Management, gained limited recognition until his story was documented in Michael Lewis' bestseller 'The Big Short.' Despite predicting the subprime mortgage crisis, Scion's AUM fe…
David Einhorn Portfolio
David Einhorn is one of the most successful long/short equity hedge fund managers of the past decade. As of July 2013, David Einhorn’s Greenlight Capital has returned 19.5% since its inception in 1996. Greenlight Capital’s market beta is around 0.5,…
David Shaw Portfolio
David Shaw is a renowned computer scientist, technological pioneer, and founder of D.E. Shaw Group, one of the earliest quantitative hedge funds. Shaw pioneered the use of algorithmic and computational modeling in institutional investing. While litt…
Michael Platt Portfolio
Michael Platt is the founder and CEO of BlueCrest Capital Management, a global macro hedge fund with a focus on systematic trading strategies. Prior to starting BlueCrest, Platt worked as a portfolio manager and trader, gaining experience across glo…📮FAQ
Some Frequently Asked Questions.
The Edwards Lifesciences Corporatio industry is Medical Devices
The Edwards Lifesciences Corporatio sector is Healthcare
The Edwards Lifesciences Corporatio forecasted predicted Price to Earnings PE ratio is 29.9
The Edwards Lifesciences Corporatio Price to Earnings PE ratio is 40.1
The Market Capitalization of Edwards Lifesciences Corporatio is $55.58B
There are total of 595329091 float shares with 84.0% held by Institutions and 0.9% held by insiders
The MEdwards Lifesciences Corporatio forecasted Earnings per Share EPS is $3.1
The Edwards Lifesciences Corporatio Earnings per Share EPS is 2.3
The Edwards Lifesciences Corporatio company has $0 gross profits with 23 profit margins
The Edwards Lifesciences Corporatio Earnings Growth is -0.061% with -0.072% quarterly earnings growth
The Edwards Lifesciences Corporatio Revenue is $6004800000 with 0.138 revenue growth
The price target for Edwards Lifesciences Corporatio stock is $105.0 for the high target and $72.0 for the low target
The consensus analyst recommendations for Edwards Lifesciences Corporatio is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Edwards Lifesciences Corporatio is Buy, with the following breakdown:
- Buy: 16
- Strong Buy: 8
- Hold: 13
- Sell: 0
- Strong Sell: 2
The Beta of Edwards Lifesciences Corporatio is 1.1
The dividend of Edwards Lifesciences Corporatio is $0
The dividend yield of Edwards Lifesciences Corporatio is 0%
The biggest institutional and mutual fund holders of Edwards Lifesciences Corporatio stock are
The Edwards Lifesciences Corporatio ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0